Event Type: The disclosure pertains to a schedule of Analyst/Institutional Investor Meetings.
Event Dates & Locations: Physical meetings are scheduled from November 16 to 18, 2026, in Taiwan and Singapore, and on November 23, 2026, in Switzerland.
Meeting Format: The meetings in Taiwan and Singapore will include both group and one-on-one sessions. The meeting in Switzerland is specified as a group meeting.
Purpose: The stated purpose is for Investor Meetings, though no specific financial period or strategic theme for discussion is mentioned.
UPSI Statement: The company has explicitly stated that "no unpublished price sensitive information is proposed to be shared during the meeting."
Management Participants: The disclosure does not list any specific management participants or their designations.
Presentation Availability: The document does not indicate that any presentation, earnings deck, transcript, or recording will be made available.
Additional Notes Section
This is a regulatory filing made under Regulation 30 and Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR).
The company's reference number for this filing is 70/26-27.
The document is a letter of intimation addressed to the National Stock Exchange of India Limited and BSE Limited.
The schedule is noted as subject to change due to exigencies on the part of the Investor or the Company.
No financial data, guidance, or strategic updates were disclosed in this announcement.
